116 related articles for article (PubMed ID: 7994282)
1. Malignant fibrous histiocytoma secondary to allogeneic bone marrow transplantation.
Iori AP; Arcese W; Pinto RM; Favre C; Macchia P
Bone Marrow Transplant; 1994 Sep; 14(3):492. PubMed ID: 7994282
[No Abstract] [Full Text] [Related]
2. Malignant fibrous histiocytoma after allogeneic bone marrow transplantation.
Vela-Ojeda J; Diaz de León L; Tripp-Villanueva F; Sanchez-Cortés E; Ayala-Sanchez M; García-Ruiz Esparza MA; Rosas-Cabral A; Gonzalez-Llaven J
Bone Marrow Transplant; 1999 Nov; 24(9):1029-31. PubMed ID: 10556964
[TBL] [Abstract][Full Text] [Related]
3. Malignant fibrous histiocytoma following bone marrow transplantation for acute leukemia.
Pesce A; Filippi C; Rosenthal E; Taillan B; Garnier G; Vinti H; Gratecos N; Poitou G; Garbe L; Michiels JF
Transplant Proc; 1993 Jun; 25(3):2299-301. PubMed ID: 8390741
[No Abstract] [Full Text] [Related]
4. Busulfan, cyclophosphamide and total body irradiation as conditioning for allogeneic bone marrow transplantation for acute and chronic myeloid leukemia.
Hirabayashi N; Goto S; Ishii M; Yuge M; Mitsuma A; Noda N
Bone Marrow Transplant; 1998 Jun; 21(11):1079-83. PubMed ID: 9645568
[TBL] [Abstract][Full Text] [Related]
5. Olfactory neuroblastoma as a second malignant neoplasm in a patient previously treated for childhood acute leukemia.
Kounami S; Douno S; Matsubara H; Takayama J; Ohira M
Pediatr Hematol Oncol; 2001; 18(7):459-63. PubMed ID: 11594709
[TBL] [Abstract][Full Text] [Related]
6. Malignant diseases after allogeneic bone marrow transplantation: an updated overview.
Socié G; Henry-Amar M; Devergie A; Esperou-Bourdeau H; Ribaud P; Traineau R; Gluckman E
Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S75-7. PubMed ID: 8177721
[TBL] [Abstract][Full Text] [Related]
7. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
[TBL] [Abstract][Full Text] [Related]
8. Long-term remissions in patients with myelodysplastic syndrome and secondary acute myelogenous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550 cGy total body irradiation and cyclophosphamide.
Hallemeier CL; Girgis MD; Blum WG; Brown RA; Khoury HJ; Devine SM; Vij R; Lin HS; DiPersio JF; Adkins DR
Biol Blood Marrow Transplant; 2006 Jul; 12(7):749-57. PubMed ID: 16785064
[TBL] [Abstract][Full Text] [Related]
9. [Donor cell-derived acute myeloid leukemia developed shortly after allogeneic bone marrow transplantation for MDS overt leukemia].
Takahashi R; Shimazaki C; Inaba T; Nakagawa M; Yamaoka M
Rinsho Ketsueki; 2002 Oct; 43(10):963-5. PubMed ID: 12462035
[TBL] [Abstract][Full Text] [Related]
10. Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograft. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Ringdén O; Labopin M; Frassoni F; Sanz G; Demeocq F; Prentice H; Cahn JY; Barbui T; Meloni G; Schaefer U; Reiffers J; Gorin N
Bone Marrow Transplant; 1999 Aug; 24(4):389-96. PubMed ID: 10467328
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
Mehta J; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Middleton G; Eisen T; Singhal S
Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189
[TBL] [Abstract][Full Text] [Related]
12. Therapy-related myelodysplastic syndrome and acute myeloid leukemia after autologous bone marrow transplantation: dosis facit venenum?
Sill H; Olipitz W; Schimek MG
J Clin Oncol; 2005 Nov; 23(31):8120-1; author reply 8121-2. PubMed ID: 16258113
[No Abstract] [Full Text] [Related]
13. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
Belkacémi Y; Ozsahin M; Rio B; Laporte JP; Leblond V; Pène F; Laugier A
Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
[TBL] [Abstract][Full Text] [Related]
14. Meningioma in long-term survivors after allogeneic bone marrow transplantation.
Meignin V; Gluckman E; Gambaraelli D; Devergie A; Ramee MP; Janin A; Socié G
Bone Marrow Transplant; 1998 Oct; 22(7):723-4. PubMed ID: 9818703
[TBL] [Abstract][Full Text] [Related]
15. Secondary cancer after syngeneic bone marrow transplant.
Lipton JH; Messner HA; Dolan SP
Bone Marrow Transplant; 1995 Sep; 16(3):491-2. PubMed ID: 8535328
[No Abstract] [Full Text] [Related]
16. [Total body irradiation and bone marrow transplantation (Part I)].
Rinsho Hoshasen; 1985 May; 30(5):603-4. PubMed ID: 3897668
[No Abstract] [Full Text] [Related]
17. Unexpected recovery of ovarian function many years after bone marrow transplantation.
Rahhal SN; Eugster EA
J Pediatr; 2008 Feb; 152(2):289-90. PubMed ID: 18206705
[TBL] [Abstract][Full Text] [Related]
18. Secondary malignancies after marrow transplantation for leukemia or aplastic anemia.
Witherspoon RP; Deeg HJ; Storb R
Transplantation; 1994 May; 57(10):1413-8. PubMed ID: 8197599
[No Abstract] [Full Text] [Related]
19. [Development of cerebellar astrocytoma in a patient with acute myeloid leukemia 8 years after his second bone marrow transplant].
Matsuo K; Kondoh E; Mitome M; Takeuchi M; Matsue K
Rinsho Ketsueki; 1999 May; 40(5):427-9. PubMed ID: 10390894
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
